PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Civil Hospices of Lyon

Status: Enrolling

Conditions: Severe Infection

Treatments: Other: Description of severe infection

Study type: Observational

Funder types: Other

Identifiers

NCT06185920

69HCL23_0189

Details and patient eligibility

About

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Enrollment: 250 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
• PHAGEinLYON Clinic cohort study information notice provided to the patient

Exclusion criteria

• Opposition of trial participant

Trial design

250 participants in 1 patient group

Patients with severe infection.

Description:

Patients with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Treatment:

Other: Description of severe infection